脂質受容体のGタンパク質選択機構を解明~副作用のない治療薬開発の創薬基盤を提供~

ad

2025-12-01 京都大学

京都大学を中心とする研究グループは、重要な創薬標的であるGPCRの一種 スフィンゴシン-1-リン酸受容体3(S1PR3) が、どのGタンパク質シグナルを選択して伝達するのかという長年の課題に対し、構造学的メカニズムを解明した。クライオ電子顕微鏡による単粒子解析により、2種類の脂質(d18:1 S1P、d16:1 S1P)が結合した S1PR3–Gq複合体 の高解像度構造を決定し、受容体とGqタンパク質の間で選択的シグナル伝達を成立させる相互作用部位を特定した。これにより、不要なGタンパク質経路が誤って活性化して副作用が生じるというGPCR創薬の根本的課題に対し、狙った経路だけを活性化する薬 の合理的設計が可能になる。本成果は、副作用の少ない安全な治療薬開発の基盤として期待され、2025年PNASに掲載された。

脂質受容体のGタンパク質選択機構を解明~副作用のない治療薬開発の創薬基盤を提供~
本研究で明らかにした2種類のS1PR3-Gq複合体の全体構造

<関連情報>

ヒトスフィンゴシン-1-リン酸受容体3-Gq複合体によって明らかにされたGタンパク質サブタイプ選択性の構造的洞察 Structural insights into the G-protein subtype selectivity revealed by human sphingosine-1-phosphate receptor 3–Gq complexes

Momono Yamauchi, Dohyun Im, Shintaro Maeda, +9 , and Masatoshi Hagiwara
Proceedings of the National Academy of Sciences  Published:November 18, 2025
DOI:https://doi.org/10.1073/pnas.2507421122

Significance

Sphingosine-1-phosphate (S1P) is an important bioactive lipid that regulates numerous essential immune functions through S1P receptors (S1PR1-5). Among them, S1PR3 plays critical roles in inflammatory responses by activating the Gαq signaling pathway, leading to leukocyte rolling. Here, we determined the structures of S1PR3-Gαq complexes bound to two endogenous agonists, providing the structural basis of Gαq signaling within the S1PR family. Although these agonists share similar chemical structures, we revealed that they activate the receptor through different mechanisms. We also identified key structural interactions that enable the same G-protein-coupled receptors (GPCR) to selectively engage different G proteins. These findings offer a unique perspective on G-protein selectivity in class A GPCRs that is distinct from the conventional views.

Abstract

Sphingosine-1-phosphate (S1P) is one of the most extensively studied bioactive lipids that transduces signals via the S1P receptor (S1PR) family (S1PR1-5), a class of G-protein-coupled receptors (GPCRs), to regulate immune cell migration, vascular permeability, and pain modulation. However, the mechanism for achieving specificity in downstream signaling remains poorly understood. Here, we present cryogenic electron microscopic structures of the S1PR3-Gαq complex bound to endogenous agonists: d18:1 S1P or d16:1 S1P. Both agonists shared the same binding pocket and binding mode despite the different signaling intensities of the S1PR3-Gαq signal pathway. By comparing the structures of two agonist-bound complexes, combined with mutagenesis studies, we identified key amino acids, Phe1193.33 and Arg1363.50, that play crucial roles in differential agonist recognition and receptor activation. Furthermore, structural comparisons with previously determined S1PR3-Gαi complex or G-protein-free S1PR3 structures, along with mutagenesis analysis, revealed dynamic intracellular loop 2 conformations and specific amino acid interactions that contribute to G-protein selectivity. Notably, we identified amino acids at the 34.50 and 34.53 positions within ICL2 as critical for specific interactions with G proteins. These findings provide better understanding of the mechanism of GPCR activation and unique perspectives that can be applied to other class A GPCRs, leading to the possibility of optimized drug development.

有機化学・薬学
ad
ad
Follow
ad
タイトルとURLをコピーしました